New COVID-19 Vaccine has been Approved for Clinical Trials
About to be added to the already swollen buffet of covid-19 jabs, is a completely new kind of vaccine. One that would be administered through a skin patch.
A British company, Emergex, is currently developing a new vaccine to fight the novel coronavirus. The company is moving towards phase 1 trials and the vaccine will use T-cells to battle the virus, rather than generate an antibody response like those currently being injected.
The company has been awarded regulatory approval by Swiss authorities for clinical trials to begin and its expected that this new vaccine would have longer lasting effects, potentially for decades.
Chief Commercial Officer Robin Cohen, proudly stated that this vaccine is the first of it’s kind and no other regulator had approved clinical trials for a vaccine that only generated a T-cell response.
The clinical trials are set to start on January 3rd and will involve 26 participants. Some will receive higher doses than others and interim results are due in June.
The time frame for when this new skinpatch vaccine will be available, is around 2025 at the earliest.
Note that date is four years away…at the earliest…because that’s the normal time frame for vaccine development. Not 6 months or so like the mRNA jabs that have been unleashed on the public with very little clinical trials.
Other vaccine applications are already in the works and currently being developed is a covid-19 vaccine in pill form and also a nasal applicator.
If only those in the field of science put this much money and effort into a cure for cancer or heart disease. Of course, the goal is never to make an actual cure for anything, there’s no money in cures.
At least on the surface, this new vaccine could offer hope to those left out in the cold due to their refusal to take the current available inoculations. But, at the same time, would there be any remaining trust by then?
One of the biggest problems to come out of this is the now massive amount of vaccine hesitancy. The government mandates, threats and coercion have done what could be seen as irreversible damage to the Healthcare industry.
There was a time when doctors and nurses, topped the list for most trusted professions. These days a used car salesman would inspire more trust.
The long list of adverse reactions and the attempt to cover up the resulting injuries and deaths by health officials, only exacerbates the reluctance.
There is also skepticism about the effectiveness of the new vaccine, but what’s currently on offer doesn’t protect the recipient from getting or spreading the virus either. So, it’s a case of having to wait and see what the results of the trials are.
Danny Altmann, a professor of immunology at Imperial College London, during an interview with the Guardian, said it was unlikely that a vaccine that generates a T-cell response would provide complete protection from covid-19 and said it would likely be more effective if used in tandem with existing inoculations that generate antibody responses.
He then stated the AstraZeneca vaccine – which was banned in several countries due to recipients developing blood clotting and strokes – had a stronger T-cell response than the Pfizer vaccine but also noted the Pfizer vaccine is more effective against covid-19.
One thing is certain. If this new developing vaccine actually does do what it says it will do and does not cause the kind of adverse reactions that have been seen by those jabs available now, it will probably never get off the ground.
Remember, there is no money in cures.